Chlamydia Treatment

Chlamydia Treatment

Chlamydia is treated by a course of oral antibiotics, either as a one-time dose or as a series of pills to be taken over a period of five to ten days. People being treated for chlamydia should not have sex for a period of two weeks after treatment to make sure they cannot pass the infection to others.

Pelvic inflammatory disease (PID): Inflammation of the uterus, fallopian tubes, and ovaries caused by chlamydia or gonorrhea. It can lead to permanent inability to have children if not treated.

Reiter’s syndrome: A type of arthritis than can develop in untreated people with chlamydia.

It is characterized by inflammation of the genitals and the eyelids as well as sore and aching joints.

Trachoma: An infectious disease of the eye caused by chlamydia bacteria that can lead to blindness if untreated.

Comments

Post a Comment

Popular posts from this blog

Molecular Epidemiology of Chlamydia trachomatis Urogenital Infection.

Image
Molecula r Epidemiology of Chlamydia trachomatis Urogenital Infection 1. Introduction Each year an estimated 340 million new cases of curable sexually transmitted infections occur worldwide, with the largest proportion in the region of South and South East Asia, followed by subSaharan Africa and Latin America and the Caribbean (WHO, 2006). Chlamydia trachomatis infections are the most prevalent sexually transmitted bacteria infections recognized throughout the world. World Health Organization (WHO, 2001) estimated that there were 92 million new cases worldwide in 1999 and the incidence of infection has continued to increase each year in both industrialized and developing countries. C. trachomatis is now recognized as one the most common sexually transmissible bacterial infections among persons under than 25 years of age living in industrialized nations such as the United States, where the rate of prevalence runs at 4.2% (Miller et al., 2004). The vast majority of published cl
Read more

Host Immune Response to Chlamydia Infection

Image
Host Immune Response to Chlamydia Infection 1 . Introduction From the immunological point of view, the infections produced by intracellular bacteria have several particular features: 1. protection against intracellular bacteria is mediated by T cells, which are interacting, not directly with the pathogen, but with the infected cell surface; antibodies exhibit a minor effect on the immune protection against intracellular infections; 2. infections by intracellular bacteria is accompanied by delayed hypersensitivity reactions that occur after the local administration of soluble antigens, mediated by T cells, whose effectors are macrophages; 3. tissular reactions to anti- intracellular bacteria are granulomatous in nature, both the protective responses and pathology being caused by them. Breaking granuloma favors pathogen dissemination and extension of lesions; 4. intracellular bacteria are expressing little or no toxic effects to the host cell, and pathology results f
Read more

Manipulation of Host Vesicular Trafficking and Membrane Fusion During Chlamydia Infection.

Image
Manipulation of Host Vesicular Trafficking and Membrane Fusion During Chlamydi a Infection 1. Introduction Chlamydia infections are associated with a wide range of diseases. C. trachomatis (serovars A, B, Ba and C) causes trachoma, the world’s leading cause of infectious blindness. Serovars D through K are most commonly associated with sexually transmitted diseases and can cause infertility in women if left untreated [Paavonen and Eggert-Kruse, 1999]. Sexually transmitted diseases (STDs) are prevalent in every society in the world, including in developed countries (United States Centers for Disease Control [CDC]). Therefore, they represent a serious public health concern. Public programs aimed at increasing people’s awareness of the risks these pathogens pose have helped in controlling the spread of disease. Nevertheless, Chlamydi a is still the most frequently reported STD in the United States. In 2009, 1.2 million new cases of Chlamydi a infections were reported in the Unit
Read more